Stockreport

Aclaris Therapeutics initiates a clinical trial to study ATI-50002 Topical in patients with vitiligo [Seeking Alpha]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF Aclaris Therapeutics initiates a clinical trial to study ATI-50002 Topical in patients with vitiligoAclaris Therapeutics (NASDAQ:ACRS)initiates a Phase 2 open-label clin [Read more]